Market positioning ahead of Sunday's constitutional referendum suggests guarded optimism after weekly gains for Italian stocks.
Morgan Stanley slashes the valuation of its holding in India's leading local e-commerce player Flipkart to $5.54 billion as opposed to $15.5 billion at its peak.
Howard Schultz, 63, will step down, effective April 3, 2017, the global coffee powerhouse Starbucks said, just days ahead of its annual meeting with investors. Starbucks Original logo, pictured.
With OPEC's news on oil production limits, gold investors are losing their grip.
The president-elect's pick for Transportation Secretary made at least $1.1 million last year as a corporate director, highlighting her ability to revolve between government service and the private sector.
The five companies have a combined valuation of nearly $200 billion; by remaining private, they feel insulated from economic uncertainty and market volatility.
The latest populist wage protests will come to a head for many companies in 2017.
Wall Street still thinks Whole Foods is an unsubstantiated risk, even with management reconstruction afoot.
It's showtime for one of Nike's biggest product releases in recent memory, the Hyperadapt 1.
Jill Stein's recount efforts aren't going to win her the presidency. What they will get her is donor data potentially worth millions of dollars.
Burger King is looking to an old friend to jump-start sales headed into 2017.
The beloved fast-food chain is rolling out these new burgers in an effort to please quality-conscious consumers. Will it thaw out investors as well?
On Black Friday and Cyber Monday, Hasbro (HAS) toys remained the most sought-after items at brick-and-mortar retailer Target (TGT) and on e-commerce site Amazon.com (AMZN).
Want to send wine for the holidays? The process is now overflowing with some true bah humbug. Here's a guide on what you need to know.
A nanotechnology derived artificial red blood cell could be used in life-saving situations like trauma accidents or the battlefield where donated blood is unavailable.
Spark believes temporary treatment with steroids can arrest the immune response before it causes factor IX levels to fall to a point where bleeding risk becomes a problem.
Check out Jim and TheStreet editorial team’s latest analysis and commentary on what’s moving markets now.